Mid
S
SGRYAI Stock Diagnostic Report
Surgery Partners reaffirms 2026 revenue $3.35B-$3.45B and adjusted EBITDA at least $530M as Idaho Falls sale nears close
Surgery Partners has reaffirmed its 2026 revenue and adjusted EBITDA guidance and is approaching the final stages of the sale of Idaho Falls.
View Source Article ↗
AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
SGRY Analysis History (Last 30 Days)